SEC Tracker
Get the app

Replimune Group REPL

Lewis Tanya (Affiliate) plans to sell 22,486 REPL shares, about $527,297

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Jun 13, 2023
  2. Broker: J.P. Morgan Securities LLC
  3. Shares acquired by: RSU Vesting
  4. 10b5-1 plan adopted: Mar 15, 2023

All of Lewis Tanya's insider filings, holdings and planned sales

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Replimune Group files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Heron Therapeutics HRTX public float $235M, Jun 30, 2025
  2. Aldeyra Therapeutics ALDX public float $232M, Jun 30, 2025
  3. Sagimet Biosciences SGMT public float $228M, Jun 30, 2025
  4. Annexon ANNX public float $244M, Jun 30, 2025
  5. Lifecore Biomedical LFCR public float $223M, Jun 30, 2025